These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265 [TBL] [Abstract][Full Text] [Related]
6. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS). Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829 [TBL] [Abstract][Full Text] [Related]
7. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia. Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498 [TBL] [Abstract][Full Text] [Related]
8. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816 [TBL] [Abstract][Full Text] [Related]
15. [Accessory use of protease-inhibiting agents for disease remission in a patient with autoimmune hemolytic anemia associated with B-CLL]. Ijichi S; Sano Y; Une F; Maruyama I; Osame M Rinsho Ketsueki; 1990 Feb; 31(2):219-23. PubMed ID: 2329684 [TBL] [Abstract][Full Text] [Related]
16. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia. Efremov DG; Ivanovski M; Burrone OR Leuk Lymphoma; 1998 Jan; 28(3-4):285-93. PubMed ID: 9517500 [TBL] [Abstract][Full Text] [Related]
17. Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma. Herishanu Y; Levi S; Kamdjou T; Bornstein Y; Ram R; Benyamini N; Varon D; Avivi I; Perry C Br J Haematol; 2021 Jan; 192(1):e1-e4. PubMed ID: 33095444 [No Abstract] [Full Text] [Related]
18. Intractable autoimmune hemolytic anemia in B cell chronic lymphocytic leukemia resolved by Rituximab. Shvidel L; Shtalrid M; Berrebi A Leuk Lymphoma; 2004 Jul; 45(7):1493-4. PubMed ID: 15359657 [No Abstract] [Full Text] [Related]
19. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Diehl LF; Ketchum LH Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530 [TBL] [Abstract][Full Text] [Related]
20. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma. Win N; Tiwari D; Keevil VL; Needs M; Lakhani A Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]